ONCY:NASDAQ
Oncolytics Biotech Inc
US$0,63
arrow_downward
-1,59%(-0,010) 1D
US$0,65
arrow_upward
+3,00% (+0,019)bedtimeAfter hours
Closed: 2 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
US$0,65
High
US$0,65
Low
US$0,62
Mkt. cap
80,46 ລ້ານ
Avg. vol.
969,28 ພັນ
Volume
611,81 ພັນ
52-wk high
US$1,42
52-wk low
US$0,62
Beta
1,15
Shares outstanding
127,51 ລ້ານ
No. of employees
29
Open
US$0,65
High
US$0,65
Low
US$0,62
Mkt. cap
80,46 ລ້ານ
Avg. vol.
969,28 ພັນ
Volume
611,81 ພັນ
52-wk high
US$1,42
52-wk low
US$0,62
Beta
1,15
Shares outstanding
127,51 ລ້ານ
No. of employees
29
News stories
From web sources and news partners
Seeking Alpha
·
38 ນາທີກ່ອນ
AI spending to drive another strong S&P 500 earnings season, Goldman Sachs says
Simply Wall Street
·
41 ນາທີກ່ອນ
One MoneyHero Limited (NASDAQ:MNY) Analyst Is Reducing Their Forecasts For This Year
Mott Capital Management
·
1 ຊົ່ວໂມງກ່ອນ
Broad Inflation Keeps Treasury Yields in Focus and Downward Pressure on the S&P 500
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
Headquartersຄັລກາຣີ, ອັລເບີທາ, ແຄນາດາ
SectorBiotechnology
Websiteoncolyticsbiotech.com